<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01769976</url>
  </required_header>
  <id_info>
    <org_study_id>APP1023401</org_study_id>
    <nct_id>NCT01769976</nct_id>
  </id_info>
  <brief_title>Effects of Periodic Fasting Versus Daily Energy Restriction on Metabolic Health</brief_title>
  <acronym>PREFER</acronym>
  <official_title>Effects of Periodic Fasting Versus Daily Energy Restriction on Metabolic Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Adelaide</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Adelaide</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine whether periodic fasting improves markers of diabetes
      risk and cardiovascular health, and will compare this to the effects observed with daily
      dieting by energy restriction, and also with no change in energy intake.

      It is hypothesized that periodic fasting, with or without weight loss, will be as effective
      as daily energy restriction to improve markers of metabolic health and energy metabolism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>8 weeks</time_frame>
    <description>assessed by hyperinsulinemic euglycemic clamp</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma hormones and adipokines</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function, hunger, and mood</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress, stress resistance, and lipid metabolism</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>8 weeks</time_frame>
    <description>resting energy expenditure, and total daily energy expenditure</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Daily energy restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25% reduction in daily energy intake</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Energy balance diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diet provides 100% of energy requirements and is designed to achieve weight stability</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodic fasting with weight loss</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fast 3 days per week, and consume 1.5 times usual amount of food on other days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodic fasting without weight loss</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fast 3 days per week, and consume double usual amount of food on other days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Periodic fasting</intervention_name>
    <arm_group_label>Periodic fasting with weight loss</arm_group_label>
    <arm_group_label>Periodic fasting without weight loss</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Energy restriction</intervention_name>
    <arm_group_label>Daily energy restriction</arm_group_label>
    <arm_group_label>Periodic fasting with weight loss</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Energy balance diet</intervention_name>
    <arm_group_label>Energy balance diet</arm_group_label>
    <arm_group_label>Periodic fasting without weight loss</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) between 25 and 42 kg/m2

          -  weight stable (&lt;5% fluctuation in body weight for the 6 months prior to study entry)

        Exclusion Criteria:

          -  history of cardiovascular disease, diabetes, major psychiatric disorders, and eating
             disorders

          -  use of prescribed or non-prescribed medications with may affect energy metabolism,
             gastrointestinal function, body weight, or appetite

          -  recent weight changes in 3 months prior to study entry

          -  uncontrolled asthma, current fever, upper respiratory infections

          -  individuals who regularly perform high intensity exercise (&gt;2 sessions per week)

          -  pregnancy, lactation (breast feeding), women who are planning to become pregnant

          -  current intake of &gt;140g of alcohol per week

          -  current smoker of cigarettes/cigars/marijuana

          -  current intake of any illicit substance

          -  experience claustrophobia in confined spaces

          -  has donated blood within the past 3 months

          -  unable to comprehend the study protocol

          -  experiences migraines
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonie Heilbronn</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Adelaide</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5005</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2013</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Adelaide</investigator_affiliation>
    <investigator_full_name>A/Prof Leonie Heilbronn</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

